Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran
-
Hamid Reza Goli
,
Mohammad Reza nahaei
,
Mohammad Ahangarzadeh-Rezaee
,
Alka Hasani
,
Hossein Samadi Kafil
,
Mohammad Aghazadeh
Abstract
Background and Objectives: The prevalence of multidrug resistant Pseudomonas aeruginosa is the main reason of new drugs resurgence such as colistin. The main objectives of this study were to determine the antibiotic resistance pattern and the rate of colistin resistance along with its correlation with overexpression of MexAB-OprM and MexXY-OprM efflux pumps among P. aeruginosa isolates.
Materials and Methods: Hundred clinical isolates were collected from 100 patients during 6 months in 2014. Susceptibility to the eight antibiotics was investigated using Kirby-Bauer and agar dilution methods. The Quantitative Real-time PCR was used to determine the expression levels of efflux genes.
Results: Resistance rates to various antibiotics were as follows: ticarcillin (73%), ciprofloxacin (65%), aztreonam (60%), ceftazidime (55%), gentamicin (55%), imipenem (49%), piperacillin/tazobactam (34%) and colistin (2%). In disk diffusion method, only two isolates were non susceptible to colistin, however in agar dilution method the two isolates were confirmed as resistant and two others were intermediate resistant. Sixty eight (68%) isolates were multi-drug resistant and 10 isolates were susceptible to all tested antibiotics. Both colistin resistant isolates showed overexpression of both efflux pumps, but two intermediate resistant isolates exhibited reduction of efflux genes expression.
Conclusions: Emergence of colistin resistance is increasing in P. aeruginosa indicating great challenge in the treatment of infections caused by MDR strains of this organism in Iran. ParRS may promote either induced or constitutive resistance to colistin through the activation of distinct mechanisms such as MDR efflux pumps, and LPS modification.
Dhariwal AK, Tullu MS. Colistin: re-emergence of the 'forgotten' antimicrobial agent. J Postgrad Med 2013;59: 208-15.
Martis N, Leroy S, Blanc V. Colistin in multi-drug re- sistant Pseudomonas aeruginosa blood-stream infec- tions: a narrative review for the clinician. J Infect 2014;69: 1-12.
Hachem RY, Chemaly RF, Ahmar CA, Jiang Y, Bok- tour MR, Rjaili GA, et al. Colistin is effective in treat- ment of infections caused by multidrug-resistant Pseu- domonas aeruginosa in cancer patients. Antimicrob Agents Chemother 2007; 51: 1905-11.
Fernandez L, Gooderham WJ, Bains M, McPhee JB, Wiegand I, Hancock RE. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimi- crob Agents Chemother 2010; 54: 3372-3382.
Lee JY, Na IY, Park YK, Ko KS. Genomic variations between colistin-susceptible and -resistant Pseudomo- nas aeruginosa clinical isolates and their effects on colistin resistance. J Antimicrob Chemother 2014; 69:1248-56.
Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resis- tant Gram-negative bacterial infections. Clin Infect Dis 2005; 40: 1333-1341.
Fernando DM, Kumar A. Resistance-nodulation-divi- sion multidrug efflux pumps in Gram-negative bacte- ria: role in virulence. Antibiotics 2013; 2: 163-81.
Guénard S, Muller C, Monlezun L, Benas P, Brou- tin I, Jeannot K, et al. Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa. Antimi- crob Agents Chemother 2014; 58: 221-228.
Forbes BA, Sahm D, Weissfeld A (2005). Diagnostic microbiology. St Louis: Mosby.
Wayne PA (2014). Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: Twenty-fourth informational supplement, M100-S24. Clinical and Laboratory Stan- dards Institute (CLSI); vol(34), No.1.
Hojabri Z, Ahangarzadeh Rezaee M, Nahaei MR, So- roush MH, Ghojazadeh M, Pirzadeh T, et al. Compar- ison of in-vitro activity of doripenem versus old car- bapenems against Pseudomonas aeruginosa clinical isolates from both CF and Burn patients. Adv Pharm Bull (APB) 2013; 3: 121-125.
Oh H, Stenhoff J, Jalal S, Wretlind B. Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb Drug Resist 2003; 9: 323-328.
Fazeli H, Sadighian H, Esfahani BN, Pourmand MR.Molecular epidemiology and mechanisms of antimi- crobial resistance in Pseudomonas aeruginosa isolates causing burn wound infection in Iran. J Chemother 2014; 26: 222-228.
Dumas J-L, van Delden C, Perron K, Köhler T. Anal- ysis of antibiotic resistance gene expression in Pseu- domonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol Lett. 2006; 254: 217-225.
Pfaffl MW. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res 2001; 29: e45.
Yousefi S, Nahaei MR, Farajnia S, Aghazadeh M, Iversen A, Edquist P, et al. A multiresistant clone of Pseudomonas aeruginosa sequence type 773 spread- ing in a burn unit in Orumieh, Iran. APMIS : Acta pathol Microbiol et Immunol Scand 2013; 121: 146-52.
Neyestanaki DK, Mirsalehian A, Rezagholizadeh F, Jabalameli F, Taherikalani M, Emaneini M. Determi- nation of extended spectrum beta-lactamases, metal- lo-beta-lactamases and AmpC-beta-actamases among carbapenem resistant Pseudomonas aeruginosa isolat- ed from burn patients. Burns 2014; 40: 1556-1561.
Shahcheraghi F, Nikbin VS, Feizabadi MM. Identifica- tion and genetic characterization of metallo-beta-lact- amase-producing strains of Pseudomonas aeruginosa in Tehran, Iran. New Microbiol 2010; 33: 243-8.
Sheikh AF, Rostami S, Jolodar A, Amin M. Detection of Metallo-Beta Lactamases Among Carbapenem-Re- sistant Pseudomonas aeruginosa. Jundishapur J Mi- crob 2014; 7: e12289.
Bayram Y, Parlak M, Aypak C, Bayram I. Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey. Int J Med Sci 2013;10: 19-23.
Gill MM, Usman J, Kaleem F, Hassan A, Khalid A, Anjum R, et al. Frequency and antibiogram of multi- drug resistant Pseudomonas aeruginosa. JCPSP 2011; 21: 531-534.
Pamp SJ, Gjermansen M, Johansen HK, Tolker-Niel- sen T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to meta- bolically active cells, and depends on the pmr and mex- AB-oprM genes. Mol Microbiol 2008; 68: 223-240.
Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res 2003;2: 48-62.
Poole K, Lau CH-F, Gilmour C, Hao Y, Lam JS. Poly- myxin susceptibility in Pseudomonas aeruginosa linked to the MexXY-OprM multidrug efflux system. Antimicrob Agents Chemother 2015; 59: 7276-89.
Muller C, Plésiat P, Jeannot K. A two-component reg- ulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemo- ther 2011; 55: 1211-21.
van der Heijden IM, Levin AS, De Pedri EH, Fung L, Rossi F, Duboc G, et al. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins. Ann Clin Microbiol Antimicrob 2007; 6: 8.
Bergen PJ, Li J, Rayner CR, Nation RL. Colistin meth- anesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemo- ther 2006; 50: 1953-8.
Gales AC, Reis AO, Jones RN. Contemporary assess- ment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available inter- pretative criteria and quality control guidelines. J Clin Microbiol 2001; 39: 183-190.
Hogardt M, Schmoldt S, Gotzfried M, Adler K, Hee- semann J. Pitfalls of polymyxin antimicrobial suscep- tibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother 2004; 54: 1057-1061.
Mirsalehian A, Feizabadi M, Nakhjavani FA, Jaba- lameli F, Goli H, Kalantari N. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns 2010; 36: 70-74.
| Files | ||
| Issue | Vol 8 No 1 (2016) | |
| Section | Articles | |
| Keywords | ||
| Pseudomonas aeruginosa Resistance Multidrug resistant MIC Polymyxins Colistin Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
